"With our multi-disciplinary approach to treating malignancies today, our technology and our evidence-based treatment protocols will result in superior outcomes for our patients. New technologies, such as Varian RapidArc™, offer more efficient delivery of radiation treatment and Calypso ('GPS for the Body" ®), enables us to deliver higher, more effective doses of radiation to the prostate with fewer complications and side effects," said Dr. Rose, Chief Technology Officer of VRA and Vantage Oncology.
Dr. Yampolsky, who has a strong background in computer sciences and biochemistry, is pleased with the new joint venture and seeks to build upon the center's history of innovation. "Our center will strive to be the leader in cancer care in this market by proactively assessing newer technologies that enhance the comfort, convenience, and treatment quality for our patients."
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
As part of the joint venture agreement, Vantage Oncology will provide operations management and funding for facility and technology upgrades to support the center's efforts to provide academic quality cancer care in a patient-friendly environment.
"We are looking forward to this new joint venture with Vantage Oncology because it provides us with an outstanding platform for maximizing the quality of oncologic care in Beverly Hills and surrounding communities," said Dr. Botnick.
About Valley Radiotherapy Associates Medical Group, Inc.
Valley Radiotherapy Associates Medical Group, Inc. (VRA) of Manhattan Beach, California, was founded by Leslie E. Botnick, M.D., and Christopher M. Rose, M.D., in June, 1983 to deliver radiation oncology services. Today, VRA Medical Group has 34 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California. VRA has distinguished itself during the past 25 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit www.valley-radiotherapy.com.
About Vantage Oncology
Founded in October 2002, Manhattan Beach, California-based Vantage Oncology, LLC, develops and operates radiation oncology centers of excellence through acquisitions and joint ventures. The company's founding principals was to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology currently operates 46 treatment facilities in 13 states. Vantage Oncology is led by a seasoned management team including Chief Executive Officer and Co-Founder Michael Fiore, Chief Medical Officer and Co-Founder, Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. For more information about Vantage Oncology, visit www.vantageoncology.com.
